GLOBAL GENE CORP LIMITEDActive
Key figures
Like most small UK companies, GLOBAL GENE CORP LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2019/20–2025/26
| 2020/21 | 2021/22 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 117,967 | 206,458 | 3,722 | 2,678 | 1,774 |
| Total assets | — | — | — | — | — |
| Total liabilities | — | — | — | 2,237,314 | 915 |
| Net assets / total equity | -1,628,234 | -2,125,170 | -2,236,937 | -2,234,636 | 859 |
| Average number of employees | 3 | 3 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: GLOBAL GENE CORP LIMITED
Company
GLOBAL GENE CORP LIMITED is a private limited company registered with Companies House under company number 09640272. It was incorporated on 16 Jun 2015. Its status is active. The registered office is in Fareham (PO16). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025/26 (period ending 30 Jun 2026); the company files small company accounts (filleted). Net assets were £859, up 100% on the previous year. Cash at bank and in hand was £1,774. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Mar 2028. The next confirmation statement is due by 30 Jun 2027.